Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Determining control parameters for dendritic cell-cytotoxic T lymphocyte interaction.

Burkhard Ludewig1, Philippe Krebs, Tobias Junt

  • 1Institute of Experimental Immunology, University of Zürich, Zürich, Switzerland. burkhard.ludewig@kssg.ch

European Journal of Immunology
|August 13, 2004
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dynamic alterations in the irradiated draining lymph node.

NPJ precision oncology·2026
Same author

Myocardial Immune Niches in Homeostasis and Inflammation.

Immunological reviews·2026
Same author

PMGen: from peptide-MHC structure prediction to peptide generation.

Bioinformatics (Oxford, England)·2026
Same author

Targeting the miR-19b/PPP2R5E axis enhances temozolomide response in glioblastoma via ROS-induced DNA damage.

British journal of cancer·2026
Same author

The roles and diversity of alarmins in the mucosae.

Advances in immunology·2026
Same author

IL-33-induced ILC2 effector cytokine responses promote the expansion of red pulp macrophages.

Proceedings of the National Academy of Sciences of the United States of America·2026

Dendritic cells (DC) and cytotoxic T lymphocytes (CTL) interaction dynamics were modeled. Optimal immunotherapy depends on T cell receptor avidity and recipient T cell availability, not just DC numbers.

Area of Science:

  • Immunology
  • Computational Biology
  • Cancer Immunotherapy

Background:

  • Dendritic cells (DC) are crucial for initiating T cell responses, including cytotoxic T lymphocytes (CTL).
  • DC-based immunotherapy shows promise for cancer treatment but is limited by incomplete understanding of DC-CTL interactions.
  • Kinetics and regulatory mechanisms governing DC-CTL interactions require further elucidation for therapeutic optimization.

Purpose of the Study:

  • To analyze the population dynamics of DC-induced CTL responses using a combined experimental and modeling approach.
  • To identify key parameters regulating the efficiency of DC-mediated CTL induction.
  • To inform strategies for enhancing DC-based immunotherapeutic efficacy.

Main Methods:

  • Integrated experimental mouse studies with mathematical modeling and nonlinear parameter estimation.

Related Experiment Videos

  • Developed a predator-prey model to describe DC-CTL interactions.
  • Incorporated non-linear compartmental dynamics of T cells into the model.

    • Main Results:

    • T cell receptor avidity, DC half-life, and CTL-mediated DC elimination rate are critical control parameters.
    • A minimal threshold of approximately 200 transferred DC per spleen is sufficient for high avidity CTL induction.
    • The number of adoptively transferred DC is less important than other factors once this threshold is met.

    Conclusions:

    • Successful DC-based immunotherapy relies on optimizing T cell receptor avidity and the application regimen.
    • Availability of high avidity T cells in the recipient is paramount.
    • Future strategies should focus on enhancing T cell avidity and tailoring treatment schedules for improved outcomes.